Prince Mahidol Award Foundation Under the Royal Patronage by Prof. Dr. Apichart Asawamongkolkul, Vice President of the Prince Mahidol Award Foundation. The recipients of the Prince Mahidol Award for the year 2023, including Prof. Dr. Napoleone Ferrara and Prof. Dr. Barry H. Rumack, were brought to present to His Majesty the King to receive the award. On this occasion, His Majesty the King His Majesty graciously granted Somdet Phra Kanitthathirachao Her Royal Highness Princess Maha Chakri Sirindhorn went out on his behalf The Prince Mahidol Award was presented at the Chakri Maha Prasat Throne Hall. Grand Palace
On this occasion, Her Royal Highness Princess Maha Chakri Sirindhorn, Her Royal Highness Princess Maha Chakri Sirindhorn Princess Maha Chakri Sirindhorn His Majesty the King gave a speech on the work of Professor Dr. Napoleone Ferrara who discovered and extracted VeGF protein. which accelerates the growth of blood vessel lining cells This is an important factor that makes many types of cancer and age-related macular degeneration more severe. This led to the development of anti-VEGF protein drugs. To treat such diseases with the work of Professor Dr. Barry H. Rumack, who studied the toxic effects of paracetamol overdose Then devise a risk assessment tool that leads to appropriate diagnosis and treatment of paracetamol poisoning. It is beneficial to the health and quality of life of people around the world. I would like to express my admiration for the two recipients of the 2023 Prince Mahidol Award for their work resulting from diligence and diligence. Sacrifice, patience and the greatest compassion for fellow human beings
The recipient of the 2023 Prince Mahidol Award in the medical field is Prof. Napoleone Ferrara, M.D., Senior Deputy Director of Basic Sciences, Moores Cancer Center. Faculty of Medicine University of California, San Diego, USA, has made a breakthrough by discovering and extracting a protein that accelerates the growth of blood vessel lining cells. or VEGF protein The results of this study led to the development of an antibody drug against the VeGF protein, including bevacizumab (Evastin), which is used to treat patients with advanced stage cancer. with dense blood vessel formation, including brain cancer, lung cancer, cervical cancer, ovarian cancer, and colon cancer
In the field of public health: Prof. Barry H. Rumac, M.D., professor emeritus Department of Pediatrics and Emergency Medicine Faculty of Medicine University of Colorado, USA, who is interested in studying the pharmacology and toxicology of paracetamol. that is the cause of acute liver failure in 40-70 percent of patients worldwide Prof. Barry H. Rumak's research into paracetamol toxicity has led to innovations that have been used to save the lives of millions of patients around the world.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.